Biblio
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer. Wien Klin Wochenschr. 2022.
. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). Eur J Cancer. 2020;132:43-52.
.